Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 1,111

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Depression and Parkinson's disease: a review

·1992·American Journal of Psychiatry

Abstract

OBJECTIVE: The purpose of this review is to provide an update of the research regarding depression in Parkinson's disease and to synthesize the information into a neurobiological model relating the structural and biochemical changes in this disorder to the behavioral manifestations. METHOD: The author used a computer-based search of the literature, augmented by extensive bibliography-guided article reviews, to find information on depression and Parkinson's disease. FINDINGS: Depression occurs in approximately 40% of patients with Parkinson's disease; depression in Parkinson's disease is distinguished from other depressive disorders by greater anxiety and less self-punitive ideation. Lower CSF levels of 5-hydroxyindoleacetic acid, a past history of depression, and greater functional disability are associated with a greater risk of depression in Parkinson's disease. Female gender, early age at onset of Parkinson's disease, and greater left brain involvement may also be risk factors. Approximately half of depressed patients with Parkinson's disease meet criteria for major depressive episodes; half have dysthymia. Depression is more common in Parkinson's disease with prominent bradykinesia and gait instability than in tremor-dominant syndromes. Depressed patients with Parkinson's disease have greater frontal lobe dysfunction and greater involvement of dopaminergic and noradrenergic systems than nondepressed patients with the disease. Mood changes in Parkinson's disease respond to treatment with conventional tricyclic antidepressants or ECT. CONCLUSIONS: Neurobiological investigations suggest that depression in Parkinson's disease may be mediated by dysfunction in mesocortical/prefrontal reward, motivational, and stress-response systems. Neuropsychological, metabolic, clinical, pharmacological, and anatomical studies support the involvement of frontal dopaminergic projections in patients with Parkinson's disease and depression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1176/ajp.149.4.443

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 94

  1. 10.1056/NEJM198911163212004 · DOI · Paper page
  2. 10.1001/archneur.1989.00520420033021 · DOI · Paper page
  3. 10.1001/archneurpsyc.1922.02190120032002 · DOI
  4. Mjones H, 1949, Acta Psychiatr Neurol Suppt, 54, 1
  5. 10.1136/bmj.2.5452.33 · DOI
  6. Hoehn MM, Yahr MD: Parkinsonism: onset, progression, and mortality. Neurology I 967
  7. Warburton JW, Depressive symptoms in Parkinson patients referred for thatamotomy. J Neurot Neurosurg Psychiatry I 967
  8. Cetesia GG, 1972, Dis Nerv Syst, 33, 577
  9. 10.1097/00007611-197205000-00008 · DOI
  10. 10.1017/S0033291700007467 · DOI
  11. Lesser RP, Isgreen WP
  12. 10.1002/ana.410060409 · DOI · Paper page
  13. 1980, Parkinson's Disease: Current Progress, Problems, and Management
  14. 10.1212/WNL.31.6.645 · DOI · Paper page
  15. 10.1136/jnnp.49.4.381 · DOI · Paper page
  16. 10.1176/ajp.143.6.756 · DOI · Paper page
  17. 10.1192/bjp.149.6.720 · DOI
  18. 10.1093/brain/109.2.279 · DOI
  19. Kostic VS, Nikotic M
  20. Huber SJ, 1988, Paulson GW
  21. 10.1017/S0033291700001872 · DOI · Paper page
  22. 10.1016/0093-934X(88)90142-3 · DOI
  23. 10.1080/01688638908400918 · doi:10.1080/01688638908400918
  24. 10.1001/archneur.1989.00520480026014 · DOI
  25. 10.1097/00005053-199001000-00005 · DOI · Paper page
  26. 10.1017/S0033291700013246 · DOI
  27. 10.1001/archneur.1984.04050200041016 · DOI
  28. 10.1136/jnnp.47.9.983 · DOI
  29. 10.1001/archneur.1986.00520090026011 · DOI
  30. 10.1136/jnnp.51.11.1401 · DOI · Paper page
  31. 10.1176/jnp.1.2.154 · doi:10.1176/jnp.1.2.154
  32. 10.1212/WNL.38.9.1402 · DOI · Paper page
  33. 10.1001/archneur.1988.00520280079019 · doi:10.1001/archneur.1988.00520280079019
  34. 10.1016/S0010-9452(89)80059-0 · doi:10.1016/s0010-9452(89)80059-0
  35. Beatty WW, 1989, J Geriatr Psychiatry Neurol, 2, 22, 10.1177/089198878900200106 · DOI
  36. Ehmann TS, Gawel Mi
  37. 10.1136/jnnp.53.4.275 · DOI
  38. 10.1136/jnnp.53.10.869 · DOI
  39. 10.1136/jnnp.37.1.27 · DOI
  40. Dubois B, Agid Y: Age-induced cognitive disturbances in Parkinson's disease. Neurology I 990
  41. 10.1007/BF00314500 · DOI
  42. 10.1212/WNL.39.11.1441 · DOI
  43. Mayeux R, 1984, Neurotogy, 34, 642
  44. 10.1192/bjp.128.2.141 · DOI
  45. 10.1016/0021-9681(74)90032-0 · doi:10.1016/0021-9681(74)90032-0
  46. 10.1176/ajp.145.8.1020 · DOI
  47. 10.1002/mds.870030308 · DOI
  48. Pfeiffer RF, 1987, Adv Neurot, 45, 439
  49. 10.1016/0006-3223(87)90156-9 · DOI
  50. Kuhn W, Early Diagnosis and Preventive Therapy in Parkinson's Disease
  51. 10.1002/mds.870050106 · DOI
  52. 10.1016/0006-3223(90)90525-7 · DOI
  53. 10.1001/archpsyc.1989.01810030049007 · DOI · Paper page
  54. Kostic VS, Susic V, Przedborski S, Sternic N: Steep EEG in depressed and nondepressed patients with Parkinson's disease. J Neuropsychiatry Clin Neurosciences I 991 ; 3:176-1 79
  55. 10.1002/cne.902870308 · DOI · Paper page
  56. 10.1001/archneur.1988.00520290025008 · DOI · Paper page
  57. 10.1002/ana.410220207 · DOI
  58. 10.1212/WNL.40.10.1529 · DOI · Paper page
  59. 10.1016/0165-1781(85)90035-6 · DOI
  60. 10.1001/archneur.1986.00520100009006 · DOI
  61. 10.1177/089198878800100106 · DOI · Paper page
  62. 10.1176/jnp.1.3.263 · DOI
  63. Brown RG, 1984, J Neurot Neurosurg Psychiatry, 47, S4
  64. Cantello R, Gitti M, Riccio A, Bergamasco B: Mood changes associated with "end-of-dose deterioration" in Parkinson's disease: a controlled study. J Neurol Neurosurg Psychiatry I 986; 49:1182-1190 · DOI
  65. Freidenberg DL, Cummings JL: Parkinson's disease, depression, and the on-off phenomenon. Psychosomatics 1 989
  66. 10.1136/jnnp.49.6.657 · DOI
  67. 10.1093/brain/107.2.487 · DOI · Paper page
  68. 10.1017/S0033291700000702 · DOI
  69. 10.1002/mds.870050210 · DOI · Paper page
  70. 10.1016/0165-0327(83)90006-X · DOI
  71. Ruggieri S, 1986, J Neural Transm Suppl, 22, 227
  72. Birkmayer W, Deprenyl (selegitine) in the treatment of Parkinson's disease. Acta Neurol Scan 1983
  73. Goetz CG, Tanner CM, Penn RD, Stebbins GT III, Gitley DW, Shannon KM, Klawans HL, Comelta CL, Wilson RS, Witt T: Adrenal medutlary transplant to the striatum of patients with advanced Parkinson's disease: 1 -year motor and psychomotor data. Neurology 1 990; 40:273-276 · doi:10.1212/wnl.40.2.273
  74. 10.1111/j.1600-0404.1980.tb03028.x · DOI
  75. 10.1111/j.1600-0404.1969.tb01224.x · DOI
  76. 10.1212/WNL.34.8.1092 · DOI
  77. 10.1136/jnnp.52.6.724 · DOI
  78. 10.1016/0006-3223(85)90028-9 · DOI
  79. 10.1016/S0033-3182(88)72375-0 · DOI
  80. 10.1176/ajp.134.2.191 · DOI
  81. 10.1176/ajp.146.8.1088 · DOI
  82. Lebensohn ZM, Jenkins RB: Improvement of parkinsonism in depressed patients treated with ECT. Am J Psychiatry I 975
  83. 10.1016/S0010-440X(79)80010-3 · DOI
  84. 10.1159/000117534 · DOI
  85. Jeltinger K, 1986, Adv Neurot, 45, 1
  86. 10.1212/WNL.30.12.1326 · DOI · Paper page
  87. Hornykiewicz 0, 1986, Adv Neurot, 45, 19
  88. Barbeau A, Handbook of Clinical Neurology, vol 5(49): Extrapyramidal Disorders
  89. 10.1212/WNL.36.4.556 · DOI
  90. Javoy-Agid F, Recent Devetopments in Parkinson's Disease. Edited by Fahn 5, Marsden CD, Jenner P, Teychenne P.
  91. 10.1016/S0166-2236(84)80145-9 · DOI · Paper page
  92. 10.1017/S0317167100046230 · DOI
  93. Taylor AE, Saint-Cyr JA: Depression in Parkinson's disease: reconciting physiological and psychological perspectives. J Neuropsychiatry Clin Neurosciences I 990
  94. 10.1177/089198879000300102 · DOI

Cited by

See all 1,111

Metadata

Venue
American Journal of Psychiatry
Published
1992-04-01
Volume
149
Issue
4
Pages
443-454
ISSN
  • 0002-953X (ISSN-L)
  • 1535-7228
OpenAlex
W1506736245
Cited by
1,111
References
4
FWCI
23.18
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Depression and Parkinson's disease: a review. https://app.cochat.ai/papers/10.1176/ajp.149.4.443
The paper
Depression and Parkinson's disease: a review. (1992). American Journal of Psychiatry. https://doi.org/10.1176/ajp.149.4.443

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.